NIH-funded research R01 grant

Right heart remodeling in pulmonary hypertension

Official title: Right ventricle remodeling in pulmonary hypertension

Funded at Ohio State University · NIH-11533159 · Data updated 2026-11-12

In people with pulmonary hypertension, researchers are studying how the right side of the heart changes and why it fails, with the goal of finding new treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2026
Award (this year)$48,386
NIH project number3R01HL167963-03S1
Project IDNIH-11533159 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with pulmonary hypertension whose right heart function is impaired and who might benefit from future therapies derived from this research.

Less likely to help

Patients without right heart dysfunction related to pulmonary hypertension or those not eligible for future trials may not benefit from the direct outcomes.

What this research studies

This project looks at how the right ventricle behaves differently from the left ventricle in pulmonary hypertension and why drugs that help the left ventricle may not help the right. It uses animal models to compare the biology of the two ventricles, focusing on immune and fibrotic processes. The team plans to use gene expression analysis and flow cytometry to understand cell types and signaling in the stressed right ventricle. The ultimate aim is to uncover new, targeted ways to treat right heart dysfunction instead of relying on transplantation.

Why it matters

Potential benefit: If successful, the work could lead to new therapies that protect or repair the right ventricle in pulmonary hypertension, potentially reducing the need for transplantation.

How similar studies have gone: Previous work has shown distinct differences between the right and left ventricles in disease, supporting the potential for targeted therapies to emerge from this line of study.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Gorr, Matthew William — Ohio State University
  • Study coordinator: Gorr, Matthew William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.